Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Methotrexate | 0.31623 | uM | 3 | 156.25 | 49.48 | 79.33 | 96.33 | 0.8212 | 0.6123 |
| BT-20 | Taxol | 0.01 | uM | 3 | 156.25 | 49.48 | 63.67 | 96.33 | 0.6492 | 0.2446 |
| BT-20 | Omipalisib | 1 | uM | 3 | 156.25 | 49.48 | 39.50 | 96.33 | 0.4161 | -0.2093 |
| BT-20 | Methotrexate | 0.1 | uM | 3 | 156.25 | 49.48 | 74.00 | 96.33 | 0.7681 | 0.5062 |
| BT-20 | Taxol | 0.00016596 | uM | 3 | 156.25 | 49.48 | 111.33 | 96.33 | 1.1734 | 1.4475 |
| BT-20 | Taxol | 0.0031623 | uM | 3 | 156.25 | 49.48 | 65.67 | 96.33 | 0.6775 | 0.3109 |
| BT-20 | Omipalisib | 0.01 | uM | 3 | 156.25 | 49.48 | 111.33 | 96.33 | 1.1409 | 1.2528 |
| BT-20 | Omipalisib | 0.31623 | uM | 3 | 156.25 | 49.48 | 38.00 | 96.33 | 0.3966 | -0.2514 |
| BT-20 | Methotrexate | 0.0016596 | uM | 3 | 156.25 | 49.48 | 98.00 | 96.33 | 1.0168 | 1.0281 |
| BT-20 | Methotrexate | 0.031623 | uM | 3 | 156.25 | 49.48 | 130.33 | 96.33 | 1.3604 | 1.8139 |
| BT-20 | Methotrexate | 3.1623 | uM | 3 | 156.25 | 49.48 | 101.00 | 96.33 | 1.0729 | 1.2452 |
| BT-20 | Methotrexate | 10 | uM | 3 | 156.25 | 49.48 | 88.67 | 96.33 | 0.9392 | 0.9218 |
| BT-20 | Taxol | 0.00033113 | uM | 3 | 156.25 | 49.48 | 90.00 | 96.33 | 0.9571 | 0.9836 |
| BT-20 | Taxol | 0.001 | uM | 3 | 156.25 | 49.48 | 95.67 | 96.33 | 0.9936 | 0.9856 |
| BT-20 | Omipalisib | 0.0016596 | uM | 3 | 156.25 | 49.48 | 125.33 | 96.33 | 1.3284 | 1.8460 |
| BT-20 | Omipalisib | 0.0033113 | uM | 3 | 156.25 | 49.48 | 109.67 | 96.33 | 1.1309 | 1.2507 |
| BT-20 | Omipalisib | 0.031623 | uM | 3 | 156.25 | 49.48 | 63.00 | 96.33 | 0.6658 | 0.3118 |
| BT-20 | Omipalisib | 0.1 | uM | 3 | 156.25 | 49.48 | 44.33 | 96.33 | 0.4567 | -0.1327 |
| BT-20 | Omipalisib | 3.1623 | uM | 3 | 156.25 | 49.48 | 22.33 | 96.33 | 0.2307 | -0.5712 |
| BT-20 | Omipalisib | 10 | uM | 3 | 156.25 | 49.48 | 30.33 | 96.33 | 0.3149 | -0.4126 |
| BT-20 | Methotrexate | 0.0033113 | uM | 3 | 156.25 | 49.48 | 88.33 | 96.33 | 0.9286 | 0.8774 |
| BT-20 | Methotrexate | 0.01 | uM | 3 | 156.25 | 49.48 | 111.00 | 96.33 | 1.1461 | 1.2986 |
| BT-20 | Methotrexate | 1 | uM | 3 | 156.25 | 49.48 | 94.33 | 96.33 | 0.9826 | 0.9767 |
| BT-20 | Taxol | 0.1 | uM | 3 | 156.25 | 49.48 | 57.00 | 96.33 | 0.5966 | 0.1596 |
| BT-20 | Taxol | 0.031623 | uM | 3 | 156.25 | 49.48 | 61.67 | 96.33 | 0.6418 | 0.2467 |